Investor profile
Will Denehy
Venture capital, Venture debt & Vice President at Catalio Capital Management
Will Denehy is a Vice President at Catalio Capital Management, whose known portfolio counts 19 companies.
Is Will Denehy a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
- Focus
- BioinformaticsBiotechDiagnosticsDrug DiscoveryDrug Discovery PlatformGeneticsGenomicsLife ScienceMachine LearningTherapeutics
Contacts
Affiliated funds' portfolios
Vice President at Catalio Capital Management, whose known portfolio counts 19 companies
- Parabilis Medicines
- Beacon Biosignals
- Noetik
- Imperative Care
- COMPASS Pathways
- Character Biosciences
- Medra AI
- Orasis Pharmaceuticals
- Aviceda Therapeutics
- DNA Script
- Imbria Pharmaceuticals
- Somethings
- and 7 more
Investor Profile
Will Denehy is listed against sectors AI and Healthcare, and focus areas Bioinformatics, Biotech, Diagnostics and Drug Discovery in the database.
Catalio Capital Management appears in Growth, Late-Stage and Seed rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Will Denehy matches their raise.
Colleagues at Catalio Capital Management
George Petrocheilos
Co-Founder & Managing Partner
New York, United States
Matthew J. Hobson
Principal
New York, United States
Jonathan Blankfein
Investor
New York, United States
R. Jacob Vogelstein
Co-Founder
Washington, United States
Benjamin Bell
PhD, CFA - Biotech Investor
Baltimore, United States
Tom Brooks
General Partner
Baltimore, United States
John Henry Iucker
General Partner
New York, United States
Frequently asked questions
Who is Will Denehy?
Will Denehy is a venture capital investor and venture debt investor based in United Kingdom, listed as Vice President at Catalio Capital Management. The known portfolio of that firm counts 19 companies. That portfolio belongs to the firm, not to Will Denehy personally.
What does Will Denehy invest in?
Listed sectors include AI and Healthcare; listed focus areas include Bioinformatics, Biotech, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Will Denehy invest at?
Catalio Capital Management appears in Growth, Late-Stage and Seed rounds across its known deals, and Will Denehy is listed there as Vice President. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Will Denehy listed at?
Will Denehy is listed as Vice President at Catalio Capital Management. 7 other people in the database share a firm with Will Denehy.
How do I contact Will Denehy?
An email address, a phone number and a LinkedIn page are on file for Will Denehy. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal